EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fetal Fraction Signatures: A Quality Control Tool to Detect Potentially Confounding Situations in NonInvasive Prenatal Diagnosis of Monogenic Conditions

Jean-Louis Blouin, Claudine Rieubland, Thierry Nouspikel iD

Clinical Genetics · 2025

DOI: 10.1111/cge.70121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genetics, 2025. Verfasst von Jean-Louis Blouin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Genetic Medicine, Diagnostic Department, Geneva University Hospitals, Geneva, Switzerland. Hauptthemen laut MEDLINE: Noninvasive Prenatal Testing, Prenatal Diagnosis, Genetic Diseases, Inborn, Cell-Free Nucleic Acids. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Noninvasive prenatal diagnosis relies on the analysis of the small amount of cell‐free fetal DNA circulating in maternal plasma. Widely used to screen for chromosomal anomalies, the technique can also be applied to Mendelian diseases (NIPD‐M). However, asserting the presence of a maternal variant in the fetus is challenging and requires the determination of the maternal haplotypes transmitted to the fetus. This is achieved via relative haplotype dosage (RHDO), a method that relies on the analysis of the allelic balance of multiple single‐nucleotide polymorphisms around the pathogenic variant. An inherent risk of this method is that twin pregnancies and chromosomal anomalies like trisomy, monosomy or uniparental disomy unavoidably alter allelic balance, potentially leading to incorrect diagnosis. Here, we introduce an analytical method, fetal fraction signatures, that can detect such confounding situations in NIPD‐M data, without the need for additional wet‐lab work. We show that our method can reliably detect anomalies down to a low level of mosaicism and a low fetal fraction, thereby providing an essential quality‐control tool for clinical testing by NIPD‐M.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Noninvasive Prenatal TestingPrenatal DiagnosisGenetic Diseases, InbornCell-Free Nucleic AcidsHumansFemalePregnancyQuality ControlFetusHaplotypesPolymorphism, Single NucleotideMosaicism

Stichwörter der Autor:innen

circulating cell‐free DNAfetal DNAmonogenic diseasenoninvasive prenatal diagnosis

Substanzen

Cell-Free Nucleic Acids

Autor:innen und Institutionen

  • Genetic Medicine, Diagnostic Department, Geneva University Hospitals, Geneva, Switzerland.
  • Department of Genetic Medicine and Development, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Department of Medical Genetics, Central Institute of the Hospitals, Hospital of the Valais, Sion, Switzerland.

ORCID-Profile: Thierry Nouspikel

Zitieren

APA

Blouin, J. L., Rieubland, C., & Nouspikel, T. (2025). Fetal Fraction Signatures: A Quality Control Tool to Detect Potentially Confounding Situations in NonInvasive Prenatal Diagnosis of Monogenic Conditions. Clinical Genetics. https://doi.org/10.1111/cge.70121

Vancouver

Blouin JL, Rieubland C, Nouspikel T. Fetal Fraction Signatures: A Quality Control Tool to Detect Potentially Confounding Situations in NonInvasive Prenatal Diagnosis of Monogenic Conditions. Clinical Genetics. 2025. doi:10.1111/cge.70121

BibTeX
@article{Blouin2025,
  author = {Blouin, Jean-Louis and Rieubland, Claudine and Nouspikel, Thierry},
  title = {Fetal Fraction Signatures: A Quality Control Tool to Detect Potentially Confounding Situations in NonInvasive Prenatal Diagnosis of Monogenic Conditions},
  journal = {Clinical Genetics},
  year = {2025},
  doi = {10.1111/cge.70121}
}
Kostenlos starten →